Company / Current Liabilities
LEXICON PHARMACEUTICALS, INC. Current Liabilities History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$20.9M
FY2025
5-year range
$20.9M / $45.2M
FY2021-FY2025
Trend
-53.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 10 years, ranging from $19M in FY2013 to $165M in FY2016.
Based on SEC 10-K filings.
$21M in FY2025 with a 10-year CAGR of -16.3%.
Improved from $32M to $21M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -16.3%
Key checks
Key Insights
- In FY2025, current liabilities decreased 53.9% year-over-year.
- Peak current liabilities was recorded in FY2016.
- Lowest current liabilities in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.9M | -53.9% |
| FY2024 | $45.2M | +43.4% |
| FY2023 | $31.5M | +36.1% |
| FY2019 | $23.2M | -36.9% |
| FY2018 | $36.8M | -70.4% |
| FY2017 | $124.1M | -24.6% |
| FY2016 | $164.6M | +33.9% |
| FY2015 | $123.0M | +173.5% |
| FY2014 | $45.0M | +133.1% |
| FY2013 | $19.3M | +5.5% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026